ECP

ImmunoCAP ECP measures the level of eosinophil cationic protein (ECP) in serum.

A high level of serum ECP indicates inflammation which is a risk factor for asthmatic patients. Measuring ECP in a serum sample is an objective and direct way of estimating the severity of airway inflammation and following the course of disease in asthmatic patients.

Clinical importance in asthma

ImmunoCAP ECP serum measurements can be used:

To monitor inflammation in asthma
To guide corticosteroid treatment in asthma
To find non-compliant patients

Download Quality Club ECP Directions for Use

ImmunoCAP ECP helps to identify ongoing inflammation associated with asthma and aids in determining appropriate therapy for asthmatic patients

Technical details

Healthy adults demonstrated levels with a geometric mean of 5.5 μg/l
Healthy children demonstrated levels with a geometric mean of 5.9 μg/l
Blood collection tubes, coagulation time and temperature must be kept within specified limits as these factors will affect the concentration of released ECP in serum samples
Plasma and haemolysed serum should not be used